posts category

Press Room

SEOUL, South Korea–Macrogen, Inc. (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on August 13 that its two next-generation sequencing (NGS) clinical laboratories, located in its Seoul headquarters and Bundang Precision Medicine Center, respectively, received the College of American Pathologists …

Continue reading

Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest – Macrogen establishes ‘Macrogen Asia Pacific’, a Subsidiary in Singapore – Targeting Southeast Asian market…Focus on large-scale genome analysis project SEOUL, South Korea–Macrogen, Inc. (President Ji-young Moon, www.macrogen.com) (KOSDAQ …

Continue reading

CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment research and development Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com), a precision medicine biotechnology company, announced on April 5 that it …

Continue reading

ROCKVILLE, MD– Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs …

Continue reading

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading